Equities

Stella Pharma Corp

4888:TYO

Stella Pharma Corp

Actions
  • Price (JPY)479.00
  • Today's Change7.00 / 1.48%
  • Shares traded297.60k
  • 1 Year change+61.28%
  • Beta1.9173
Data delayed at least 20 minutes, as of Nov 14 2024 05:16 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
OPERATIONS
Net income(761)(776)(764)
Depreciation/depletion353534
Non-Cash items6.58(1.29)7.85
Cash taxes paid, supplemental2.853.630.94
Cash interest paid, supplemental2.082.583.10
Changes in working capital(157)(85)(359)
Total cash from operations(877)(828)(1081)
INVESTING
Capital expenditures(11)(29)(46)
Other investing and cash flow items, total1.97(0.6)(304)
Total cash from investing(9.01)(30)(351)
FINANCING
Financing cash flow items0.1014373
Total cash dividends paid------
Issuance (retirement) of stock, net3884383,617
Issuance (retirement) of debt, net(160)(160)(160)
Total cash from financing2282923,829
NET CHANGE IN CASH
Foreign exchange effects------
Net change in cash(657)(566)2,398
Net cash-begin balance/reserved for future use2,6703,236838
Net cash-end balance/reserved for future use2,0122,6703,236
SUPPLEMENTAL INCOME
Depreciation, supplemental353534
Cash interest paid, supplemental2.082.583.10
Cash taxes paid, supplemental2.853.630.94
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.